glp-1 receptor agonist common side effects The expanding role of agonists: a narrative review of current evidence and future directions Long-Term Effects Of GLP-1 Medications:
Description
Both belong to the incretin mimetic drug class but differ in their mechanisms: Zepbound activates both GLP-1 and GIP receptors, while Wegovy targets only GLP-1
doi: 10.3390/ijms20215407
10.3389/fcvm.2021.720690 24 EneboL
With continued research and collaboration between academia, industry, and clinicians, GLP-1based interventions have the potential to address complex metabolic diseases more comprehensively, shaping the next generation of treatments and improving outcomes for patients worldwide
Role of the signal peptide in the synthesis and processing of the glucagon-like peptide-1 receptor
PMID: 21209017
